Celgene hunts deals to offset loss of Revlimid patent protection via @FT
https://t.co/SNcvLynpAN— The Propell Group (@ThePropellGroup) April 9, 2018
Celgene hunts deals to offset loss of Revlimid patent protection via @FT
https://t.co/SNcvLynpAN— The Propell Group (@ThePropellGroup) April 9, 2018